Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKinsey
Johnson and Johnson
Baxter
Boehringer Ingelheim

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

A-METHAPRED Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

US ANDA Litigation and Generic Entry Outlook for A-methapred

A generic version of A-METHAPRED was launched as methylprednisolone sodium succinate by FRESENIUS KABI USA on December 14th, 2019.

Summary for A-METHAPRED
Drug patent expirations by year for A-METHAPRED
Synonyms for A-METHAPRED
.delta.(sup 1)-6-.alpha.-Methylhydrocortisone
.DELTA.1-6.alpha.-Methylhydrocortisone
(6.alpha.,11.beta.)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(Medrol
(Medrone[6-alpha-Methyl-11 beta, 17d,21-trihydroxy-1,4-pregnadiene-3,20-dione
1,4-Pregnadiene-3,20-dione, 11beta,17alpha,21-trihydroxy-6alpha-methyl-
11-.beta.,17-.alpha.,21-Trihydroxy-6-.alpha.-methyl-1,4-pregnadiene-3,20-dione
11-.beta.,17,21-Trihydroxy-6-.alpha.-methylpregna-1,4-diene-3,20-dione
11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione, (6.alpha.,11.beta.)- #
14,17-dihydroxy-14-(2-hydroxyacetyl)-2,8,15-trimethyltetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadeca-3,6-dien-5-one
6-.alpha.-Methylprednisolone
6a_Methylprednisolone
AC1L1HJP
AC1Q5HK2
AKOS024386987
BBL033955
CHEMBL190259
HMS3086J15
I06-0969
M-Prednisol
MCULE-5764697777
MEPRDL
MLS002638721
Prednisolone, 6.alpha.-methyl-
Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-6-methyl-, (6.alpha.,11.beta.)-
Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-
Pregna-1,4-diene-3,20-dione, 6.alpha.-methyl-11.beta.-17,21-trihydroxy-
SCHEMBL541256
SMR001496976
ST51039058
STL372918
Urbazone
VHRSUDSXCMQTMA-UHFFFAOYSA-N

US Patents and Regulatory Information for A-METHAPRED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089576-001 Feb 22, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 040664-001 Dec 20, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Abbott A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089575-001 Feb 22, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 089173-001 Aug 18, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira A-METHAPRED methylprednisolone sodium succinate INJECTABLE;INJECTION 085853-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Express Scripts
Dow
Mallinckrodt
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.